Breast Cancer Deadline 2020® Third Annual Progress Report Released

Image

Today, NBCC is releasing their Breast Cancer Deadline 2020® Third Annual Progress Report to the public. Each year since the launch of Breast Cancer Deadline 2020®, NBCC has released an annual report on the progress in breast cancer and in NBCC’s work to achieve the deadline. This year’s report provides an update with the latest data on breast cancer incidence and mortality as well as news about treatment options; information on public policy, advocacy, and the media’s coverage of breast cancer; a look at the current research priorities as demonstrated by research funding; and finally, an update on Breast Cancer Deadline 2020® activities.

I hope that you will read the Progress Report and share it with others. Then, please join Fran Visco for a Q&A conference call next Thursday, October 17 at 3:30pm ET.

Call-in Instructions
Dial 866-818-1223 and an operator will connect you to the conference call. They will allow time to answer as many questions as we can during the call.

As you read the Progress Report, you will note that overall, the results are disappointing. However, we also see some promise that the tide is indeed turning as more of the breast cancer community focuses on the goals of Breast Cancer Deadline 2020®—preventing people from getting the disease and stopping people from dying of it.

A few highlights:

  • Breast cancer incidence and mortality remained essentially unchanged since 2011. Mortality rates appear to be decreasing slowly—but that is certainly not progress. In fact, the rate of decrease in mortality seems to be slowing, rather than increasing.
  • There were no major advances in treatment for breast cancer in the last year. In the past year, the FDA approved three drugs for the treatment of metastatic breast cancer, with only one of the drugs showing an improvement in overall survival.
  • The amount of research focusing on metastasis is greater than two years ago. While federal funding of breast cancer research overall has decreased in the last two years, the proportion of research funds coded in the area of breast cancer progression and metastasis has increased during that same period.

To read much more about these topics and others, please read the full Progress Report. And, then join NBCC with your questions next Thursday at 3:30pm ET.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: